YNL190W Antibody

What is YNL190W and what organism is it found in?

YNL190W is a gene in Saccharomyces cerevisiae (baker's yeast) that encodes a hypothetical protein. It is classified in genomic databases as a protein necessary for cellular fitness. The gene is part of the yeast genome and has been cataloged in the Saccharomyces Genome Database with specific identifiers including Entrez Gene ID 855531 .

YNL190W has been shown to play a role in cellular longevity, as deletion of this gene results in decreased mean replicative lifespan in both alpha and a strains of yeast . While it is designated as a hypothetical protein, experimental evidence suggests functional importance in cellular processes related to aging and fitness.

What is known about the structure and function of YNL190W protein?

• Deletion of the gene decreases mean replicative lifespan in yeast cells

• It falls under the longevity category of being "necessary for fitness"

• No homologs have been identified in other organisms according to genomic analyses

The specific molecular mechanisms through which YNL190W influences cellular aging remain an active area of investigation. The protein's structural features, domains, and precise biochemical functions require further characterization.

What are the best methods for validating YNL190W antibody specificity?

When validating antibodies against YNL190W, researchers should implement a multi-faceted approach:

• Western blotting validation:

  • Compare signal between wild-type and YNL190W deletion strains

  • Verify the protein appears at the expected molecular weight

  • Include pre-adsorption controls with recombinant protein

• Immunofluorescence controls:

  • Compare localization patterns in wild-type vs. deletion strains

  • Include peptide competition assays

  • Use alternative antibodies targeting different epitopes for confirmation

• Immunoprecipitation validation:

  • Confirm pulled-down protein identity via mass spectrometry

  • Assess enrichment compared to control IgG

  • Verify absence of signal in YNL190W deletion strains

The experimental design should account for the characteristics of YNL190W as a yeast protein with potential post-translational modifications that might affect epitope accessibility .

How should I optimize cell preparation for YNL190W immunodetection?

For optimal detection of YNL190W in yeast cells:

• Cell wall removal: Since yeast cells have a rigid cell wall, proper digestion with enzymes like laminarinase (at 0.25 U/ml, 37°C for 1 hour) is essential for antibody accessibility .

• Fixation optimization:

  • Test paraformaldehyde fixation (4%, 15-30 minutes)

  • Compare with methanol fixation (-20°C, 5 minutes)

  • Evaluate effects of different crosslinkers on epitope preservation

• Protein extraction: For western blotting, use buffer containing protease inhibitors, 1 mM EDTA, and 1 mM phenylmethylsulfonyl fluoride to prevent degradation during sample preparation .

• Centrifugation parameters: After digestion, centrifuge samples at 10,000 rpm for 2 minutes at 4°C to collect the protein fraction for analysis .

This methodological approach ensures maximum protein recovery while maintaining the integrity of epitopes for antibody recognition.

How does YNL190W relate to aging pathways in yeast?

YNL190W has been identified as having implications for cellular aging, as evidenced by the observation that its deletion decreases mean replicative lifespan in yeast . When designing experiments to investigate its role in aging:

• Integrate with known aging pathways:

  • Examine interactions with established longevity regulators (TOR, sirtuins)

  • Assess whether caloric restriction modulates YNL190W function

  • Determine if YNL190W deletion affects mitochondrial function

• Design epistasis experiments:

  • Create double mutants with other aging-related genes

  • Position YNL190W in regulatory hierarchies through genetic analyses

  • Determine whether YNL190W acts in existing or novel aging pathways

• Cellular phenotype analysis:

  • Measure reactive oxygen species levels in YNL190W mutants

  • Assess stress resistance profiles

  • Quantify changes in proteostasis markers

When using antibodies to study YNL190W in aging contexts, researchers should account for potential changes in expression or localization during cellular aging processes.

What considerations are important for studying protein-protein interactions involving YNL190W?

When investigating YNL190W interactions:

• Immunoprecipitation optimization:

  • Test different lysis conditions (varying detergent types/concentrations)

  • Optimize salt concentration to preserve interactions while minimizing background

  • Include appropriate controls (IgG control, deletion strain)

• Crosslinking approaches:

  • Consider formaldehyde crosslinking for transient interactions

  • Optimize crosslinking time to capture interactions without excessive aggregation

  • Use reversible crosslinkers to facilitate downstream analysis

• Validation strategies:

  • Confirm interactions bidirectionally (reciprocal co-IP)

  • Use orthogonal methods (yeast two-hybrid, proximity labeling)

  • Validate biological relevance through functional assays

• Mass spectrometry analysis:

  • Use appropriate database parameters for yeast proteins

  • Apply stringent filtering to distinguish true interactors from contaminants

  • Consider quantitative approaches to rank interaction confidence

These methodologies should be adapted based on the specific research question and the suspected function of YNL190W in cellular processes.

How can I resolve weak or inconsistent signals when using YNL190W antibodies?

When encountering detection issues with YNL190W antibodies:

• Sample preparation optimization:

  • Ensure complete cell wall digestion using optimized enzyme concentration (0.25 U/ml laminarinase)

  • Test multiple lysis buffers to maximize protein extraction

  • Consider subcellular fractionation to concentrate the protein

• Antibody optimization:

  • Titrate antibody concentration to find optimal signal-to-noise ratio

  • Test different incubation conditions (time, temperature, blocking agents)

  • Consider alternative detection systems (enhanced chemiluminescence, fluorescence)

• Protocol modifications:

  • For membrane proteins, adjust detergent concentration to improve solubilization

  • Test different blocking agents to reduce background

  • Increase sample concentration if YNL190W is expressed at low levels

• Signal enhancement strategies:

  • Use signal amplification systems (tyramide signal amplification, polymer-based detection)

  • Optimize exposure times for western blots

  • Consider concentration steps before immunodetection

Careful optimization of each step in the protocol can significantly improve detection sensitivity and consistency.

What factors might affect YNL190W epitope accessibility and antibody binding?

Several factors can influence antibody access to YNL190W epitopes:

• Post-translational modifications:

  • N-glycosylation can mask epitopes, as observed with other yeast proteins

  • Phosphorylation may alter antibody recognition

  • Proteolytic processing could remove epitopes

• Protein conformation:

  • Native vs. denatured states may expose different epitopes

  • Fixation methods can affect protein structure and epitope accessibility

  • Detergent selection influences protein folding during extraction

• Cellular context:

  • Cell wall composition changes with growth phase

  • Protein-protein interactions may mask antibody binding sites

  • Subcellular localization can affect accessibility

• Technical considerations:

  • Fixation duration and reagents significantly impact epitope preservation

  • Temperature during antibody incubation affects binding kinetics

  • Buffer composition can influence antibody-antigen interactions

Understanding these factors is crucial for selecting appropriate antibodies and optimizing detection protocols.

How can I distinguish between specific and non-specific signals when using YNL190W antibodies?

To ensure signal specificity:

• Essential controls:

  • YNL190W deletion strain as negative control

  • Preimmune serum to assess background

  • Peptide competition assays to confirm epitope specificity

  • Secondary antibody-only controls

• Validation approaches:

  • Comparison of multiple antibodies targeting different YNL190W epitopes

  • Correlation of antibody signal with genetic expression modulation

  • Verification of molecular weight corresponds to predicted protein size

• Signal analysis methods:

  • Quantitative assessment of signal-to-noise ratio

  • Comparison of localization pattern with known protein markers

  • Assessment of signal reproducibility across experimental replicates

These strategies help distinguish genuine YNL190W detection from background or cross-reactivity with other yeast proteins.

How should I interpret YNL190W data in relation to cellular localization patterns?

When analyzing YNL190W localization data:

• Colocalization assessment:

  • Compare with established compartment markers

  • Quantify overlap using appropriate statistical methods

  • Consider three-dimensional distribution throughout the cell

• Dynamic localization analysis:

  • Track potential translocation during cell cycle progression

  • Assess changes under stress conditions

  • Monitor localization changes during aging

• Integration with functional data:

  • Correlate localization with known protein functions

  • Consider interaction partners at specific locations

  • Assess functional consequences of mislocalization

• Technical considerations:

  • Account for fixation artifacts that may alter localization patterns

  • Consider the influence of tags or antibodies on protein trafficking

  • Validate microscopy findings with biochemical fractionation approaches

Proper interpretation requires integration of localization data with functional insights to develop a comprehensive understanding of YNL190W biology.

Table 1: Key Characteristics of YNL190W

Table 2: Methodological Approaches for Cell Wall Protein Extraction in Yeast

Table 3: Experimental Controls for YNL190W Antibody Validation

What are promising approaches for further characterizing YNL190W function?

Based on current knowledge about YNL190W's role in cellular fitness and aging , promising research directions include:

• Integrative omics approaches:

  • Transcriptome analysis of YNL190W deletion effects

  • Proteome-wide interaction mapping

  • Metabolomic profiling to identify pathway alterations

• Evolutionary analysis:

  • Detailed comparative genomics for distant homologs

  • Investigation of functional analogs in other species

  • Analysis of selective pressure on the YNL190W locus

• Mechanistic investigations:

  • Structure determination via crystallography or cryo-EM

  • In vitro reconstitution of molecular activities

  • CRISPR-based precise mutagenesis of functional domains

• Systems biology integration:

  • Network analysis placing YNL190W in cellular pathways

  • Mathematical modeling of its contribution to aging

  • Integration with other longevity factors

These approaches would provide deeper understanding of YNL190W's cellular functions and its connections to aging mechanisms.

How might new antibody technologies improve YNL190W detection and characterization?

Emerging antibody technologies offer new opportunities for YNL190W research:

• Advanced antibody formats:

  • Single-domain antibodies for improved access to cryptic epitopes

  • Nanobodies for live-cell imaging applications

  • Bispecific antibodies for co-detection of interaction partners

• Superior detection methods:

  • Super-resolution microscopy compatible probes

  • Proximity ligation assays for in situ interaction studies

  • Mass cytometry for single-cell protein quantification

• Functional antibody applications:

  • Intrabodies for targeted protein modulation

  • Conformation-specific antibodies to detect structural changes

  • Split-antibody complementation for interaction monitoring

• Improved production approaches:

  • Recombinant antibodies with defined specificity

  • Antibody engineering for enhanced stability in yeast

  • Fragment-based approaches for improved cellular penetration

These technologies would enhance specificity, sensitivity, and versatility of YNL190W detection in complex biological samples.